These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6436858)
1. A dramatic behavioral response to thyrotropin-releasing hormone following low-dose neuroleptics. Garbutt JC; Loosen PT Psychoneuroendocrinology; 1984; 9(3):311-4. PubMed ID: 6436858 [TBL] [Abstract][Full Text] [Related]
2. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol. Serban G; Siegel S Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363 [TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for patients with borderline personality disorder. Gunderson JG Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871 [No Abstract] [Full Text] [Related]
4. Development of melancholia during carbamazepine treatment in borderline personality disorder. Gardner DL; Cowdry RW J Clin Psychopharmacol; 1986 Aug; 6(4):236-9. PubMed ID: 3525615 [TBL] [Abstract][Full Text] [Related]
5. Effect of tranquilizers on borderline and schizotypal patients questioned. Rockland LH Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764 [No Abstract] [Full Text] [Related]
6. Lack of effect of dopamine receptor blockade on the TSH response to TRH in borderline personality disorder. Garbutt JC; Loosen PT; Glenn M Psychiatry Res; 1987 Aug; 21(4):307-11. PubMed ID: 3114780 [TBL] [Abstract][Full Text] [Related]
7. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine. Cornelius JR; Soloff PH; Perel JM; Ulrich RF Am J Psychiatry; 1993 Dec; 150(12):1843-8. PubMed ID: 8238640 [TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Cowdry RW; Gardner DL Arch Gen Psychiatry; 1988 Feb; 45(2):111-9. PubMed ID: 3276280 [TBL] [Abstract][Full Text] [Related]
9. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo. Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532 [TBL] [Abstract][Full Text] [Related]
10. Amitriptyline versus haloperidol in borderlines: final outcomes and predictors of response. Soloff PH; George A; Nathan S; Schulz PM; Cornelius JR; Herring J; Perel JM J Clin Psychopharmacol; 1989 Aug; 9(4):238-46. PubMed ID: 2768542 [TBL] [Abstract][Full Text] [Related]